EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Customizing EV-CATCHER to Purify Placental Extracellular Vesicles from Maternal Plasma to Detect Placental Pathologies

Megan I Mitchell iD, Marwa Khalil, Iddo Z Ben-Dov iD, Jesus Alverez-Perez, Nicholas P Illsley iD, Stacy Zamudio, Abdulla Al-Khan, Olivier Loudig iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25105102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Megan I Mitchell und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ 07110, USA. Hauptthemen laut MEDLINE: Extracellular Vesicles, Placenta, Placenta Accreta. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Placenta Accreta Spectrum (PAS) is a life-threatening condition in which placental trophoblastic cells abnormally invade the uterus, often up to the uterine serosa and, in extreme cases, tissues beyond the uterine wall. Currently, there is no clinical assay for the non-invasive detection of PAS, and only ultrasound and MRI can be used for its diagnosis. Considering the subjectivity of visual assessment, the detection of PAS necessitates a high degree of expertise and, in some instances, can lead to its misdiagnosis. In clinical practice, up to 50% of pregnancies with PAS remain undiagnosed until delivery, and it is associated with increased risk of morbidity/mortality. Although many studies have evaluated the potential of fetal biomarkers circulating in maternal blood, very few studies have evaluated the potential of circulating placental extracellular vesicles (EVs) and their miRNA contents for molecular detection of PAS. Thus, to purify placental EVs from maternal blood, we customized our robust ultra-sensitive immuno-purification assay, termed EV-CATCHER, with a monoclonal antibody targeting the membrane Placental Alkaline Phosphatase (PLAP) protein, which is unique to the placenta and present on the surface of placental EVs. Then, as a pilot evaluation, we compared the miRNA expression profiles of placental EVs purified from the maternal plasma of women diagnosed with placenta previa (controls, n = 16); placenta lying low in uterus but not invasive) to those of placental EVs purified from the plasma of women with placenta percreta (cases, n = 16), PAS with the highest level of invasiveness. Our analyses reveal that miRNA profiling of PLAP+ EVs purified from maternal plasma identified 40 differentially expressed miRNAs when comparing these two placental pathologies. Preliminary miRNA pathway enrichment and gene ontology analysis of the top 14 upregulated and top nine downregulated miRNAs in PLAP+ EVs, purified from the plasma of women diagnosed with placenta percreta versus those diagnosed with placenta previa, suggests a potential role in control of cellular invasion and motility that will require further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesPlacentaPlacenta AccretaHumansFemalePregnancyBiomarkersAdultMicroRNAsPlacenta PreviaAlkaline PhosphataseIsoenzymesGPI-Linked Proteins

Stichwörter der Autor:innen

EV-CATCHERNGSONiPASPLAPabnormal placentationbiomarkerextracellular vesiclesmicroRNApercretaplacentaplacental alkaline phosphataseprevia

Substanzen

BiomarkersMicroRNAsalkaline phosphatase, placentalAlkaline PhosphataseIsoenzymesGPI-Linked Proteins

Autor:innen und Institutionen

  • Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ 07110, USA.
  • Hackensack University Medical Center, Department of Pediatrics, Hackensack Meridian Health, Hackensack, NJ 07601, USA.
  • Hackensack Meridian School of Medicine (HMHSOM), Nutley, NJ 07110, USA.
  • Laboratory of Medical Transcriptomics, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.
  • Hackensack University Medical Center, Department of Maternal and Fetal Medicine, Hackensack Meridian Health, Hackensack, NJ 07601, USA.

ORCID-Profile: Megan I Mitchell, Iddo Z Ben-Dov, Nicholas P Illsley, Olivier Loudig

Förderung

  • NICHD NIH HHS
  • National Institutes of Health

Zitieren

APA

Mitchell, M. I., Khalil, M., Ben-Dov, I. Z., Alverez-Perez, J., Illsley, N. P., Zamudio, S., Al-Khan, A., & Loudig, O. (2024). Customizing EV-CATCHER to Purify Placental Extracellular Vesicles from Maternal Plasma to Detect Placental Pathologies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105102

Vancouver

Mitchell MI, Khalil M, Ben-Dov IZ, Alverez-Perez J, Illsley NP, Zamudio S, et al. Customizing EV-CATCHER to Purify Placental Extracellular Vesicles from Maternal Plasma to Detect Placental Pathologies. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105102

BibTeX
@article{Mitchell2024,
  author = {Mitchell, Megan I and Khalil, Marwa and Ben-Dov, Iddo Z and Alverez-Perez, Jesus and Illsley, Nicholas P and Zamudio, Stacy and Al-Khan, Abdulla and Loudig, Olivier},
  title = {Customizing EV-CATCHER to Purify Placental Extracellular Vesicles from Maternal Plasma to Detect Placental Pathologies},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25105102}
}
Kostenlos starten →